Did Mutation Type Affect the Efficacy of Mexiletine Observed in Patients With LQTS Type 3?
- PMID: 28081835
- DOI: 10.1016/j.jacc.2016.06.083
Did Mutation Type Affect the Efficacy of Mexiletine Observed in Patients With LQTS Type 3?
Comment in
-
Reply: Did Mutation Type Affect the Efficacy of Mexiletine Observed in Patients With LQTS Type 3?J Am Coll Cardiol. 2017 Jan 17;69(2):248-249. doi: 10.1016/j.jacc.2016.09.981. J Am Coll Cardiol. 2017. PMID: 28081834 No abstract available.
Comment on
-
Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3.J Am Coll Cardiol. 2016 Mar 8;67(9):1053-1058. doi: 10.1016/j.jacc.2015.12.033. J Am Coll Cardiol. 2016. PMID: 26940925 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
